NASDAQ:NTBL - Nasdaq - IL0012002452 - Common Stock - Currency: USD
0.2479
-0.09 (-27.68%)
The current stock price of NTBL is 0.2479 USD. In the past month the price decreased by -45.4%. In the past year, price decreased by -90.85%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.97 | 357.10B | ||
AMGN | AMGEN INC | 15.29 | 162.72B | ||
GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
NTRA | NATERA INC | N/A | 21.43B | ||
BIIB | BIOGEN INC | 8.54 | 20.49B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Notable Labs Ltd. engages in the development of predictive medicines for patients with cancer. The company is headquartered in Foster City, California and currently employs 16 full-time employees. The company went IPO on 2014-09-30. The firm has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The firm's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
NOTABLE LABS LTD
320 Hatch Drive
Foster City CALIFORNIA US
Employees: 16
Company Website: https://notablelabs.com/
Phone: 14158512410
The current stock price of NTBL is 0.2479 USD. The price decreased by -27.68% in the last trading session.
The exchange symbol of NOTABLE LABS LTD is NTBL and it is listed on the Nasdaq exchange.
NTBL stock is listed on the Nasdaq exchange.
8 analysts have analysed NTBL and the average price target is 9.18 USD. This implies a price increase of 3603.11% is expected in the next year compared to the current price of 0.2479. Check the NOTABLE LABS LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NOTABLE LABS LTD (NTBL) has a market capitalization of 2.39M USD. This makes NTBL a Nano Cap stock.
NOTABLE LABS LTD (NTBL) currently has 16 employees.
NOTABLE LABS LTD (NTBL) has a resistance level at 0.41. Check the full technical report for a detailed analysis of NTBL support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NTBL does not pay a dividend.
NOTABLE LABS LTD (NTBL) will report earnings on 2024-11-12, after the market close.
NOTABLE LABS LTD (NTBL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.91).
ChartMill assigns a fundamental rating of 1 / 10 to NTBL. NTBL may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months NTBL reported a non-GAAP Earnings per Share(EPS) of -6.91. The EPS increased by 65.56% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -152.09% | ||
ROE | -232.9% | ||
Debt/Equity | 0.03 |
ChartMill assigns a Buy % Consensus number of 80% to NTBL. The Buy consensus is the average rating of analysts ratings from 8 analysts.